Literature DB >> 1483451

The molecular mechanism of erythropoietin action.

M J Koury1, M C Bondurant.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483451     DOI: 10.1111/j.1432-1033.1992.tb17466.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


× No keyword cloud information.
  47 in total

Review 1.  Pharmacokinetics/pharmacodynamics of recombinant human erythropoietins in doping control.

Authors:  Emmanuelle Varlet-Marie; Aurélie Gaudard; Michel Audran; Francoise Bressolle
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells.

Authors:  P A Tilbrook; E Ingley; J H Williams; M L Hibbs; S P Klinken
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

3.  Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.

Authors:  C T Quang; O Wessely; M Pironin; H Beug; J Ghysdael
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

4.  Haemoglobin mass alterations in healthy humans following four-day head-down tilt bed rest.

Authors:  Benjamin J Ryan; Jesse A Goodrich; Walter F Schmidt; Ellen R Stothard; Kenneth P Wright; William C Byrnes
Journal:  Exp Physiol       Date:  2016-03-24       Impact factor: 2.969

5.  Identification and transcriptome analysis of erythroblastic island macrophages.

Authors:  Wei Li; Yaomei Wang; Huizhi Zhao; Huan Zhang; Yuanlin Xu; Shihui Wang; Xinhua Guo; Yumin Huang; Shijie Zhang; Yongshuai Han; Xianfang Wu; Charles M Rice; Gang Huang; Patrick G Gallagher; Avital Mendelson; Karina Yazdanbakhsh; Jing Liu; Lixiang Chen; Xiuli An
Journal:  Blood       Date:  2019-05-17       Impact factor: 22.113

6.  Isolation and characterization of goat retinal microvascular endothelial cells.

Authors:  Ravinarayanan Haribalaganesh; Elayappan Banumathi; Sardarpasha Sheikpranbabu; Venkataraman Deepak; Namagiri Sirishkumar; Sangiliyandi Gurunathan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-03-07       Impact factor: 2.416

7.  Pharmacokinetic-pharmacodynamic modelling of recombinant human erythropoietin in athletes : a population approach.

Authors:  A Gaudard; E Varlet-Marie; M Audran; R Gomeni; F Bressolle
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

8.  Gene therapy for long-term expression of erythropoietin in rats.

Authors:  W R Osborne; N Ramesh; S Lau; M M Clowes; D C Dale; A W Clowes
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

9.  Apoptosis mediates and thymidine prevents erythroblast destruction in folate deficiency anemia.

Authors:  M J Koury; D W Horne
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus.

Authors:  S K Tripathy; E Goldwasser; M M Lu; E Barr; J M Leiden
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.